Cargando…
The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study
Paclitaxel exhibits clinical activity against a wide variety of solid tumors. However, resistance to paclitaxel significantly attenuates the response to chemotherapy. The ABC transporter subfamily C member 10 (ABCC10), also known as multi-drug resistance protein 7 (MRP7) efflux transporter, is a maj...
Autores principales: | Kathawala, Rishil J., Wei, Liuya, Anreddy, Nagaraju, Chen, Kang, Patel, Atish, Alqahtani, Saeed, Zhang, Yun-Kai, Wang, Yi-Jun, Sodani, Kamlesh, Kaddoumi, Amal, Ashby, Charles R., Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381611/ https://www.ncbi.nlm.nih.gov/pubmed/25402202 |
Ejemplares similares
-
PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR
por: Anreddy, Nagaraju, et al.
Publicado: (2014) -
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
por: Martiny-Baron, Georg, et al.
Publicado: (2010) -
Multidrug resistance associated proteins in multidrug resistance
por: Sodani, Kamlesh, et al.
Publicado: (2012) -
Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
por: Anreddy, Nagaraju, et al.
Publicado: (2014) -
ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel
por: Kathawala, Rishil J, et al.
Publicado: (2015)